Sheridan Capital Partners has completed its investment in Currier Plastics, appointing Andrew McLean as the new CEO to drive growth in the healthcare manufacturing sector.

Target Company Overview

Currier Plastics, founded in 1982 and headquartered in Auburn, New York, is a leading manufacturer of custom precision plastic components predominantly utilized in the healthcare and life sciences sectors. The Company has established a strong reputation for its technical expertise and dedicated service to prominent clients within demanding and heavily-regulated markets. Currier specializes in advanced custom blow and injection molding processes, producing components in ISO Class 7 and Class 8 cleanrooms. Additionally, the company provides value-added services including design engineering, material selection, and assembly, further enhancing its offerings to clients.

Industry Overview

The healthcare manufacturing industry in the United States is characterized by continuous growth and innovation, driven by advancements in technology and the ever-expanding needs of the healthcare sector. With increasing focus on patient-centric approaches and improved medical outcomes, the demand for high-quality medical device components remains robust. As a result, companies like Currier that provide tailored solutions in this niche are well-positioned to capture market share.

Furthermore, the regulatory landscape in healthcare manufacturing continues to become increasingly stringent, necessitating compliance with rigorous standards. This selective environment favors established players like Currier, which have prov